Jun 142017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, NY – Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines for patients with rare neurological disorders, today announced the appointment of Barbara G.=> Read more

Ovid Therapeutics appoints Barbara Duncan to the Board of Directors and its Audit committee

From:: Ovid Therapeutics appoints Barbara Duncan to the Board of Directors and its Audit committee

Sorry, the comment form is closed at this time.

%d bloggers like this: